Sanford Health is seeking participants for an FDA-approved clinical trial designed to explore the use of adipose stem cells to repair small and partial thickness tears in the shoulder’s rotator cuff.
This is reportedly the only trial the FDA has approved that uses adipose stem cells, taken from a person’s abdominal fat, to help heal this type of injury, according to a media release from Sanford Health, a health system headquartered in the Dakotas.
Orthopedic surgeons Jason Hurd, MD, based in Sioux Falls, SD, and Mark Lundeen, MD, from Fargo, ND, are the principal investigators.
Through liposuction, fat is removed from the abdomen, and adult stem cells are separated. Those same adult stem cells are then injected into the spot in the rotator cuff within the injured shoulder that is need of repair. The collection and injection of the adipose stem cells is done in a clinic procedure room and is completed in the same day, the release explains.
“As we work with the FDA, our goal is to develop and refine a therapy that might one day be regulated and commonly practiced in the United States because of the evidence we gather as part of this trial,” says David Pearce, PhD, executive vice president of Sanford Research, in the release.
To be eligible for this clinical trial, participants must be 30-75 years old and have a small or partial thickness rotator cuff tear. For more information, visit Sanford Health.
[Source(s): Sanford Health, Newswise]
